Neonatal jaundice screening
Jump to navigation
Jump to search
|
Neonatal jaundice Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Neonatal jaundice screening On the Web |
|
American Roentgen Ray Society Images of Neonatal jaundice screening |
|
Risk calculators and risk factors for Neonatal jaundice screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Elsaiey, MBBCH [2]
Overview
According to the American Academy of Pediatrics, screening tests recommended for neonatal jaundice include blood typing, clinical assessment of jaundice in the newborns, assessment of the total serum bilirubin level, measuring the level of G6PD enzyme. Also, it is recommended for all hospitals to provide information to the parents on jaundice and its consequences.
Screening
- According to the American Academy of Pediatrics, screening for neonatal jaundice is recommended. Screening tests include the following:[1]
- Blood typing: Testing the pregnant women for the ABO blood group and Rh autoantibodies.
- Clinical assessment: Jaundice assessment in the newborns every 8-12 hours. Assessment is performed by blanching the skin to know the color. It should be done in the daylight.
- Laboratory evaluation: Measuring the level of the total serum bilirubin level in all newborns in the first day of life.
- Estimating the cause of the jaundice: Measuring the level of the G6PD enzyme.
- Risk Assessment: The newborns should be assessed for the risk of developing jaundice before discharge.
- Also, it is recommended for all hospitals to provide information to the parents on jaundice and its consequences.
References
- ↑ American Academy of Pediatrics Subcommittee on Hyperbilirubinemia (2004). "Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation". Pediatrics. 114 (1): 297–316. PMID 15231951.